Takeda-Shitaka M - Search Results

1

Bioinformatics based Ligand-Docking and in-silico screening.

Takaya D, Takeda-Shitaka M, Terashi G, Kanou K, Iwadate M, Umeyama H. Takaya D, et al. Chem Pharm Bull (Tokyo). 2008 May;56(5):742-4. doi: 10.1248/cpb.56.742. Chem Pharm Bull (Tokyo). 2008. PMID: 18451572 Free article.

2

Dynamic characteristics of a peptide-binding groove of human HLA-A2 class I MHC molecules: normal mode analysis of the antigen peptide-class I MHC complex.

Nojima H, Takeda-Shitaka M, Kurihara Y, Adachi M, Yoneda S, Kamiya K, Umeyama H. Nojima H, et al. Chem Pharm Bull (Tokyo). 2002 Sep;50(9):1209-14. doi: 10.1248/cpb.50.1209. Chem Pharm Bull (Tokyo). 2002. PMID: 12237537 Free article.

3

Evaluation of the third solvent clusters fitting procedure for the prediction of protein-protein interactions based on the results at the CAPRI blind docking study.

Komatsu K, Kurihara Y, Iwadate M, Takeda-Shitaka M, Umeyama H; CAPRI blind docking study. Komatsu K, et al. Proteins. 2003 Jul 1;52(1):15-8. doi: 10.1002/prot.10385. Proteins. 2003. PMID: 12784361

4

Dynamic character of human growth hormone and its receptor: normal mode analysis.

Kurihara Y, Watanabe T, Nojima H, Takeda-Shitaka M, Sumikawa H, Kamiya K, Umeyama H. Kurihara Y, et al. Chem Pharm Bull (Tokyo). 2003 Jul;51(7):754-8. doi: 10.1248/cpb.51.754. Chem Pharm Bull (Tokyo). 2003. PMID: 12843579 Free article.

5

Dynamic flexibility of a peptide-binding groove of human HLA-DR1 class II MHC molecules: normal mode analysis of the antigen peptide-class II MHC complex.

Nojima H, Takeda-Shitaka M, Kurihara Y, Kamiya K, Umeyama H. Nojima H, et al. Chem Pharm Bull (Tokyo). 2003 Aug;51(8):923-8. doi: 10.1248/cpb.51.923. Chem Pharm Bull (Tokyo). 2003. PMID: 12913229 Free article.

6

Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.

Adachi M, Kurihara Y, Nojima H, Takeda-Shitaka M, Kamiya K, Umeyama H. Adachi M, et al. Protein Sci. 2003 Oct;12(10):2125-31. doi: 10.1110/ps.03100803. Protein Sci. 2003. PMID: 14500870 Free PMC article.

7

Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome.

Matsumoto M, Kokame K, Soejima K, Miura M, Hayashi S, Fujii Y, Iwai A, Ito E, Tsuji Y, Takeda-Shitaka M, Iwadate M, Umeyama H, Yagi H, Ishizashi H, Banno F, Nakagaki T, Miyata T, Fujimura Y. Matsumoto M, et al. Blood. 2004 Feb 15;103(4):1305-10. doi: 10.1182/blood-2003-06-1796. Epub 2003 Oct 16. Blood. 2004. PMID: 14563640 Free article.

8

Protein structure prediction in structure based drug design.

Takeda-Shitaka M, Takaya D, Chiba C, Tanaka H, Umeyama H. Takeda-Shitaka M, et al. Curr Med Chem. 2004 Mar;11(5):551-8. doi: 10.2174/0929867043455837. Curr Med Chem. 2004. PMID: 15032603 Review.

9

Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design.

Takeda-Shitaka M, Nojima H, Takaya D, Kanou K, Iwadate M, Umeyama H. Takeda-Shitaka M, et al. Chem Pharm Bull (Tokyo). 2004 May;52(5):643-5. doi: 10.1248/cpb.52.643. Chem Pharm Bull (Tokyo). 2004. PMID: 15133227 Free article.

10

Remarkably different structures and reaction mechanisms of ketoreductases for the opposite stereochemical control in the biosynthesis of BIQ antibiotics.

Taguchi T, Kunieda K, Takeda-Shitaka M, Takaya D, Kawano N, Kimberley MR, Booker-Milburn KI, Stephenson GR, Umeyama H, Ebizuka Y, Ichinose K. Taguchi T, et al. Bioorg Med Chem. 2004 Nov 15;12(22):5917-27. doi: 10.1016/j.bmc.2004.08.026. Bioorg Med Chem. 2004. PMID: 15498668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters